<DOC>
	<DOCNO>NCT01106053</DOCNO>
	<brief_summary>This study conduct evaluate effect drug pramipexole mood , food craving , behavior may relate binge eat disorder .</brief_summary>
	<brief_title>Pramipexole Binge Eating Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Male female Age 1850 year Women childbearing potential male must agree practice accept method birth control . All woman must negative pregnancy test baseline . Good general health demonstrate history physical examination . Body mass index 30 kg/m2 high screen visit . Meet criteria binge eat disorder assess SCID1 EDE . Subjects unstable medical condition , current past medical condition opinion study physician and/or principal investigator may increase risk associated pramipexole study participation . Medical appropriateness determine history physical exam . Subjects current Axis I psychiatric diagnosis determine Structured Clinical Interview DSMIV Axis I disorder ( SCID1 ) interview ( aside BED ) . Subjects Hamilton Depression Rating Scale score great equal 12 screen visit . Subjects report history hallucination delusion . Participants take antidepressant regularly use psychotropic medication may confound study result Subjects current history impulse control spectrum disorder , binge eat disorder , ( pathological gambling , compulsive shopping , etc . ) screen determine Structured Clinical Interview DSMIV Impulse Control Module . Subjects history suicide attempt current suicidal ideation . Subjects use tobacco product routine basis within past six month . Subjects enrol formal treatment program research protocols binge eat disorder present , within past 30 day . Subjects routinely take medication know produce weight change ( ex . olanzapine , amitriptyline , steroid medication , etc. , oral contraceptive , stable thyroid replacement drug , etc . ) , medication drugdrug interaction pramipexole . Subjects currently breastfeed . Subjects participate investigational drug trial past 30 day . Subjects meet DSM IVTR criterion alcohol drug abuse past year . Subjects allergy pramipexole tablet constituent . Subjects hepatic dysfunction determine hepatic panel obtain screen visit . Subjects elevate blood pressure pulse screening ( 140/90 mmHg pulse great 100 beats/minute seat stationary least five minute , determine discretion study physician and/or principal investigator ) history serious cardiac event ( myocardial infarction , arrhythmia , stroke , etc ) . Subjects history renal dysfunction creatinine clearance le 60 ml/min base upon serum creatinine obtain screen calculated Cockroft Gault equation . Subjects positive urine drug screen . Any participant Parkinson 's disease symptom suggestive probable Parkinson 's disease . Subjects Epworth Sleep Scale ( ESS ) score &gt; 7 screening . ESS score &gt; 7 associate increase risk sleep attack ( Plowman et al. , 2005 ) . Any participant demonstrates clinically significant orthostatic blood pressure change symptomatic screen visit , define `` orthostatic blood pressure monitoring . '' History bariatric surgery . Participants report history obstructive sleep apnea , excessive fatigue , sleep disorder opinion principal investigator study medical personnel would increase participant 's risk experience excessive somnolence pramipexole . Participant change medication regimen last month ( dose , start new medication , stop medication ) . Participant employ , immediate family member employ NRI . Participant participate formal weight loss program last month ( e.g . Weight Watchers , Jenny Craig , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Binge eat disorder</keyword>
	<keyword>Food craving</keyword>
	<keyword>Obesity</keyword>
	<keyword>Pramipexole</keyword>
	<keyword>Mirapex</keyword>
	<keyword>Binge</keyword>
</DOC>